CGBio Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
140
- Latest Deal Type
-
Buyout/LBO
- (Upcoming)
- Latest Deal Amount
-
$689M
- Investors
-
2
CGBio General Information
Description
Manufacturer of regenerative medicine products intended to enhance the quality of life for patients with spinal disorders and wound management. The company is engaged in the development of medicines for a spectrum of spinal disorders and wound management, including a comprehensive portfolio of allograft and synthetic bone grafts, spinal implants, and good manufacturing practices (GMP) grade growth factors, providing clients with medicines that address medical needs and are convenient for use in clinical settings.
Contact Information
Website
www.cgbio.co.krCorporate Office
- 1, Sangwon 12-gil
- Seongdong-gu
- Seoul, 04349
- South Korea
Corporate Office
- 1, Sangwon 12-gil
- Seongdong-gu
- Seoul, 04349
- South Korea
CGBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Buyout/LBO | $689M | Upcoming | Generating Revenue | |||
| 2. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jan-2014 | $2.84M | Completed | Generating Revenue |
CGBio Patents
CGBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026205936-A1 | Method for preparing collagen slurry, and hemostatic kit comprising same | Pending | 24-Mar-2025 | ||
| WO-2026192403-A1 | Wound dressing composition comprising hemostatic aid and method for preparing same | Pending | 14-Mar-2025 | ||
| WO-2026079852-A1 | Biomatrix and manufacturing method therefor | Pending | 07-Oct-2024 | ||
| WO-2026054593-A1 | Fish-derived acellular dermal matrix and preparation method therefor | Pending | 06-Sep-2024 | ||
| WO-2026019107-A1 | Lifting member for plastic surgery and manufacturing method therefor | Pending | 19-Jul-2024 |
CGBio Signals
CGBio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ministry of Trade, Industry and Resources | Limited Partner | |||
| Daewoong Pharmaceutical | Corporation | Majority |
CGBio Investments & Acquisitions (8)
CGBio’s most recent deal was a Merger/Acquisition with DNC Aesthetics. The deal was made on 21-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DNC Aesthetics | 21-Jul-2025 | Merger/Acquisition | Personal Products | ||
| Litian Biotechnology | 30-Apr-2025 | Joint Venture | Other Devices and Supplies | ||
| CG MedTech | 30-Oct-2024 | PIPE | Surgical Devices | ||
| CG MedTech | 27-Feb-2024 | PIPE | Surgical Devices | ||
| CG MedTech | 01-Dec-2023 | Secondary Transaction - Private | Surgical Devices |
CGBio Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| M.base | Seongnam-si, South Korea | 2017 | |
| DNC Aesthetics | Seoul, South Korea | 2001 |
CGBio FAQs
-
When was CGBio founded?
CGBio was founded in 2006.
-
Where is CGBio headquartered?
CGBio is headquartered in Seoul, South Korea.
-
What is the size of CGBio?
CGBio has 140 total employees.
-
What industry is CGBio in?
CGBio’s primary industry is Pharmaceuticals.
-
Is CGBio a private or public company?
CGBio is a Private company.
-
What is the current valuation of CGBio?
The current valuation of CGBio is .
-
What is CGBio’s current revenue?
The current revenue for CGBio is .
-
Who are CGBio’s investors?
Ministry of Trade, Industry and Resources and Daewoong Pharmaceutical have invested in CGBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process